Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

475
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
475
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

174
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
174
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

238
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
238
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

170
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
170
Vaccinations01:51

Vaccinations

49.6K
Overview
49.6K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

484
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
484

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced risk for recurrent adverse cardiovascular events in homozygous carriers of the T-allele of CD40 SNP rs1883832.

Atherosclerosis·2026
Same author

Editorial: Immunity, atherosclerosis, and cardiovascular disease: an interdisciplinary approach to cardiometabolic health.

Frontiers in cardiovascular medicine·2026
Same author

Loss of MLKL impairs abdominal aortic aneurysm development by attenuating smooth muscle cell necroptosis.

Cell death & disease·2026
Same author

Olfr2 Promotes Recruitment of Monocytes via CX3CR1 in Abdominal Aortic Aneurysm.

Circulation research·2025
Same author

Myeloperoxidase aggravates thoracic aortic aneurysm formation in Marfan disease.

Cardiovascular research·2025
Same author

An improved porcine model of infrarenal abdominal aortic aneurysm.

Scientific reports·2025
Same journal

RETRACTED: Bakshi et al. Crocin Inhibits Angiogenesis and Metastasis in Colon Cancer via TNF-α/NF-kB/VEGF Pathways. <i>Cells</i> 2022, <i>11</i>, 1502.

Cells·2026
Same journal

Correction: Verde et al. Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses. <i>Cells</i> 2025, <i>14</i>, 680.

Cells·2026
Same journal

Inflammation in Cardiomyopathies: Cellular Mechanisms Across Cardiac Phenotype.

Cells·2026
Same journal

IL-4/IL-13-Driven Dysregulation of Epidermal Lipid Metabolism in Atopic Dermatitis: An Immunometabolic Link Between Type 2 Inflammation and Barrier Dysfunction.

Cells·2026
Same journal

Activity of DNA- and RNA-Guided Prokaryotic Argonautes in Human Mitochondria.

Cells·2026
Same journal

Placental Pathophysiology in Maternal Psychoactive Substance Use: Biological, Clinical, and Forensic Perspectives.

Cells·2026
See all related articles

Related Experiment Video

Updated: Nov 27, 2025

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.5K

Vaccination in Atherosclerosis.

Felix Sebastian Nettersheim1, Lauren De Vore1, Holger Winkels1

  • 1Department III of Internal Medicine III, Heart Center, Faculty of Medicine and University Hospital of Cologne, 50937 Cologne, Germany.

Cells
|December 3, 2020
PubMed
Summary
This summary is machine-generated.

New vaccination strategies target atherosclerosis by leveraging the adaptive immune response against plaque autoantigens. This approach aims for precise treatment without compromising host defense, offering a promising therapeutic avenue for cardiovascular disease.

Keywords:
antibodiesantigen-specificapolipoprotein B (ApoB)atherosclerosisimmunizationlow-density lipoprotein (LDL)regulatory T cells (Tregs)vaccination

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.5K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.6K

Related Experiment Videos

Last Updated: Nov 27, 2025

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.5K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.5K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.6K

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Inflammation Research

Background:

  • Atherosclerosis, a primary cause of global mortality, involves chronic vascular inflammation and plaque formation.
  • Current anti-atherosclerosis treatments are limited, with inflammation-targeting therapies raising safety concerns regarding host defense impairment.
  • Decades of research link adaptive immune responses to autoantigens in plaque development (atherogenesis).

Purpose of the Study:

  • To review current vaccination strategies for atherosclerosis.
  • To explore the mechanisms of action and therapeutic potential of these immunotherapies.
  • To identify challenges in translating atherosclerosis vaccination into clinical practice.

Main Methods:

  • Review of scientific literature and preclinical data on atherosclerosis vaccination.
  • Analysis of adaptive immune responses against plaque-associated autoantigens.
  • Evaluation of proposed mechanisms of action for anti-atherosclerosis vaccines.

Main Results:

  • Preclinical studies suggest immunization against specific autoantigens offers protective effects.
  • Vaccination strategies aim to precisely target atherosclerotic plaques, potentially avoiding host defense impairment.
  • Evidence supports the role of adaptive immunity in atherogenesis, indicating potential for immunomodulation.

Conclusions:

  • Vaccination represents a promising, targeted approach for atherosclerosis treatment.
  • Further research is needed to overcome challenges for clinical translation of these immunotherapies.
  • Developing safe and effective atherosclerosis vaccines could significantly impact cardiovascular disease prevention and treatment.